Padua, Italy - Although juvenile localized scleroderma is typically thought of as a skin disease, Dr Francesco Zulian reports in the September 2005 issue of Arthritis & Rheumatism that 22.4% of ...

Localized scleroderma, as the term denotes, is localized to the skin on the hands and face. It is characterized by slow progression and rarely transforms to the systemic type. Localized scleroderma is ...

The Global Localized Scleroderma Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. The Localized Scleroderma Market is driven by rising autoimmune disease ...

Localized scleroderma is a rare connective tissue disorder characterized by hardening and thickening of the skin due to increased collagen density. A quarter of patients affected also experience ...

Patients with 3 subtypes of juvenile localized scleroderma (linear, generalized, and mixed) in the active phase were referred to a single center in Italy. They were randomly assigned in a 2:1 (active ...

Fibrocell Science has submitted an Investigational New Drug Application (IND) with the FDA for a gene therapy candidate to treat moderate to severe localized scleroderma. Fibrocell Science has ...

Long-term methotrexate therapy was a beneficial, well-tolerated treatment for juvenile localized scleroderma, according to study results. Researchers in Italy evaluated 65 patients with juvenile ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Fibrocell Science announced in a press ...